nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of treatment of muscle invasive bladder cancer using the national cancer database: Factors associated with receipt of aggressive therapy
|
Moon, Sol |
|
|
41 |
11 |
p. 456.e13-456.e20 |
artikel |
2 |
Assessing utilities for muscle-invasive bladder cancer-related health states
|
Chaballout, Basil H. |
|
|
41 |
11 |
p. 456.e7-456.e12 |
artikel |
3 |
Baseline prostate health index risk category and risk category changes during active surveillance predict grade reclassification
|
de la Calle, Claire M. |
|
|
41 |
11 |
p. 455.e1-455.e6 |
artikel |
4 |
Bladder cancer patient and provider perspectives on smoking cessation
|
Mossanen, Matthew |
|
|
41 |
11 |
p. 457.e9-457.e16 |
artikel |
5 |
Characterization of the metabolomic profile of renal cell carcinoma by high resolution magic angle spinning proton magnetic resonance spectroscopy
|
Huynh, Melissa J. |
|
|
41 |
11 |
p. 459.e9-459.e16 |
artikel |
6 |
Cover 2 - Masthead
|
|
|
|
41 |
11 |
p. IFC |
artikel |
7 |
Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer
|
Shore, Neal D. |
|
|
41 |
11 |
p. 454.e9-454.e16 |
artikel |
8 |
Editorial Board
|
|
|
|
41 |
11 |
p. i |
artikel |
9 |
Effectiveness of perioperative chemotherapy and radical cystectomy in treating bladder cancer
|
Li, Roger |
|
|
41 |
11 |
p. 457.e17-457.e24 |
artikel |
10 |
Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment
|
Minami, Keita |
|
|
41 |
11 |
p. 458.e9-458.e19 |
artikel |
11 |
Eliminating the routine use of postoperative drain placement in patients undergoing robotic-assisted radical cystectomy with intracorporeal urinary diversion
|
Rich, Jordan M. |
|
|
41 |
11 |
p. 457.e1-457.e7 |
artikel |
12 |
Extracellular vesicle biomarkers for prostate cancer diagnosis: A systematic review and meta-analysis
|
Li, Yang |
|
|
41 |
11 |
p. 440-453 |
artikel |
13 |
Incidence and predictors of deep incisional and organ/space surgical site infection following radical cystectomy
|
Blachman-Braun, Ruben |
|
|
41 |
11 |
p. 455.e17-455.e24 |
artikel |
14 |
LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patients
|
Boehle, Andreas |
|
|
41 |
11 |
p. 454.e17-454.e24 |
artikel |
15 |
Metastatic prostate cancer is associated with distinct higher frequency of genetic mutations at diagnosis
|
Al-Toubat, Mohammed |
|
|
41 |
11 |
p. 455.e7-455.e15 |
artikel |
16 |
Patient-reported outcome measures compared to clinician reported outcomes regarding incontinence and erectile dysfunction in localized prostate carcinoma after robot assisted radical prostatectomy: Impact on management
|
Tillier, CN |
|
|
41 |
11 |
p. 454.e1-454.e8 |
artikel |
17 |
Racial and sex differences in tumor genomics in urothelial carcinoma
|
Nyame, Yaw A. |
|
|
41 |
11 |
p. 456.e1-456.e5 |
artikel |
18 |
Real-world clinical outcomes of patients with metastatic renal cell carcinoma receiving pembrolizumab + axitinib vs. ipilimumab + nivolumab
|
Shah, Neil J. |
|
|
41 |
11 |
p. 459.e1-459.e8 |
artikel |
19 |
Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy
|
Yim, Kendrick |
|
|
41 |
11 |
p. 458.e1-458.e7 |
artikel |
20 |
Socioeconomic determinants of racial disparities in survival outcomes among patients with renal cell carcinoma
|
Alam, Ridwan |
|
|
41 |
11 |
p. 460.e1-460.e9 |
artikel |
21 |
2022 Star Reviewers for Urologic Oncology
|
|
|
|
41 |
11 |
p. 439.e1-439.e11 |
artikel |
22 |
Table of Contents
|
|
|
|
41 |
11 |
p. ii-iii |
artikel |